Business Merck Wins FDA Approval for First Oral PCSK9 Inhibitor Cholesterol Pill July 16, 2026 Merck announced on Thursday that the U.S. Food and Drug Administration has approved Lipfendra, marking a historic first for cholesterol treatment. The pill represents the inaugural oral PCSK9 inhibitor to…